Form IRANNOTICE NOVO NORDISK A S
Tweet
Share
E-mailU.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
January 31, 2024
Re: Notice of disclosure filed in Exchange Act Annual Report under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
Dear Sirs,
Pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended, notice is hereby provided that Novo Nordisk A/S has made disclosure pursuant to those provisions in its Annual Report on Form 20-F for the year ended December 31, 2023, which was filed with the Securities and Exchange Commission on January 31, 2024.
Sincerely,
| /s/ Lars Fruergaard Jørgensen | /s/ Karsten Munk Knudsen | |||||||
Lars Fruergaard Jørgensen President and chief executive officer | Karsten Munk Knudsen Executive vice president and chief financial officer | |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novo Nordisk (NOVOB:DC) (NVO) PT Raised to DKK285 at Jefferies
- Crypto News: AlphaPepe Reveals CEX Partnership With Biconomy As Ethereum Price Prediction Targets $7,000
- Beyond the Credential: As AI Erases the 'Entry-Level Job' and Climate Volatility Accelerates, Planet Classroom Unveils July Lineup Mapping the New Rules of Human Resilience
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
